ScholarIQanswers from OpenAlex & ORCID
Julian R. Molina
ResearcherPublications, citations & collaboration network
Julian R. Molina is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Julian R. Molina have?
ScholarIQindexed works
Julian R. Molina has 412 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Julian R. Molina have?
ScholarIQcitation count
Julian R. Molina has 25,863 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Julian R. Molina?
ScholarIQh-index
Julian R. Molina has an h-index of 56 in OpenAlex.
What is the i10-index of Julian R. Molina?
ScholarIQi10-index
Julian R. Molina has an i10-index of 141 in OpenAlex.
What is the ORCID of Julian R. Molina?
ScholarIQorcid
The ORCID for Julian R. Molina is on the source record.
What is the OpenAlex record for Julian R. Molina?
ScholarIQopenalex
The OpenAlex for Julian R. Molina is on the source record.
What are the most-cited papers on Julian R. Molina?
ScholarIQmost cited works
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
Yucai Wang, Shouhao Zhou, Fang Yang, Xinyue Qi, Xin Wang, Xiaoxiang Guan, Chan Shen, Narjust Duma, Jesus Vera Aguilera, Ashish V. Chintakuntlawar, Katharine A. Price, Julian R. Molina, Lance C. Pagliaro, Þorvarður R. Hálfdánarson, Axel Grothey, Svetomir N. Markovic, Grzegorz S. Nowakowski, Stephen M. Ansell, Michael Wang
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor Ganti, Billy W. Loo, M. Bassetti, Collin M. Blakely, Anne C. Chiang, Thomas A. D’Amico, Christopher D’Avella, Afshin Dowlati, Robert J. Downey, Martin J. Edelman, Charles Florsheim, Kathryn A. Gold, Jonathan W. Goldman, J.C. Grecula, Christine L. Hann, Wade T. Iams, Puneeth Iyengar, Karen Kelly, Maya Khalil, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian R. Molina, César A. Moran, Saraswati Pokharel, Sonam Puri, Angel Qin, Chad G. Rusthoven, Jacob Sands, Rafael Santana-Dávila, Michael Shafique, Saiama N. Waqar, Kristina M. Gregory, Miranda Hughes
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
Keith C. Bible, Vera J. Suman, Julian R. Molina, Robert C. Smallridge, William J. Maples, Michael E. Menefee, Joseph Rubin, Kostandinos Sideras, John C. Morris, Bryan McIver, Jill K. Burton, Kevin Webster, Carolyn Bieber, Anne M. Traynor, Patrick J. Flynn, Boon Cher Goh, Hui Tang, Susan Percy Ivy, Charles Erlichman